Arecor Therapeutics plc (LON:AREC – Get Free Report) shares reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 50 ($0.63) and last traded at GBX 50 ($0.63), with a volume of 50543 shares trading hands. The stock had previously closed at GBX 51.50 ($0.65).
Arecor Therapeutics Stock Down 2.9 %
The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37. The firm has a fifty day moving average price of GBX 59.94 and a 200 day moving average price of GBX 70. The firm has a market capitalization of £18.88 million, a price-to-earnings ratio of -1.77 and a beta of -0.18.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- 3 Best Fintech Stocks for a Portfolio Boost
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What Makes a Stock a Good Dividend Stock?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
